Clinical Trials List
Protocol Number3242K1-2000-WW
2009-11-01 - 2011-12-31
Phase II
Terminated1
-
Trial Applicant
Wyeth-Ayerst (Asia) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 邱瑩明 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
240 participants
